What does CUSIP 640268108 represent in this 13F holders report?

CUSIP 640268108 is the security identifier for NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value used to aggregate holder disclosures.

How many institutions held NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value in Q2 2020?

249 institutional investors reported NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value for Q2 2020. Use the holders table for investor-level position and value details.

NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)

CUSIP: 640268108

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 28,811,441
Total 13F shares: 174,896,826
Share change: -1,986,724
Total reported value: $4,050,261,692
Put/Call ratio: 74%
Price per share: $23.16
Number of holders: 249
Value change: -$44,584,638
Number of buys: 112
Number of sells: 114

Quarterly Holders Quick Answers

What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 640268108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Invesco Ltd.	13F	Company	118%	33,921,398	$605,498,000	—	31 Mar 2020	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	71%	20,482,919	$365,620,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	68%	19,514,890	$348,341,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	63%	18,069,135	$322,536,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	57%	16,521,184	$294,903,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	55%	15,746,960	$281,084,000	—	31 Mar 2020	13F
MAVERICK CAPITAL LTD	13F	Company	17%	4,898,401	$87,436,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	16%	4,631,555	$82,673,000	—	31 Mar 2020	13F
Bellevue Group AG	13F	Company	12%	3,484,713	$62,202,000	—	31 Mar 2020	13F
Camber Capital Management LP	13F	Company	10%	3,000,000	$53,550,000	—	31 Mar 2020	13F
FIRST TRUST ADVISORS LP	13F	Company	8.8%	2,524,235	$45,058,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	8.4%	2,432,006	$43,411,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	7.3%	2,111,172	$37,684,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	6.3%	1,813,950	$32,379,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	6.2%	1,800,466	$32,138,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	5.1%	1,460,454	$26,068,000	—	31 Mar 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	4.9%	1,404,610	$25,072,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	4.2%	1,205,226	$21,514,000	—	31 Mar 2020	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	3.9%	1,126,206	$20,103,000	—	31 Mar 2020	13F
Rhenman & Partners Asset Management AB	13F	Company	3.7%	1,075,000	$19,189,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	2.9%	836,712	$14,936,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	2.4%	681,763	$12,170,000	—	31 Mar 2020	13F
OSTERWEIS CAPITAL MANAGEMENT INC	13F	Company	2.3%	676,496	$12,075,000	—	31 Mar 2020	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	2%	583,525	$10,416,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	2%	578,965	$10,334,000	—	31 Mar 2020	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	1.9%	556,906	$9,941,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	1.7%	475,580	$8,489,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	1.6%	471,035	$8,408,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.6%	470,233	$8,394,000	—	31 Mar 2020	13F
S.c.a. Candriam	13F	Individual	1.3%	386,000	$8,145,000	—	31 Mar 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	1.3%	388,548	$6,936,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	1.3%	363,978	$6,497,000	—	31 Mar 2020	13F
KBC Group NV	13F	Company	1.2%	358,535	$6,400,000	—	31 Mar 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.2%	353,563	$6,310,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	1.2%	349,461	$6,237,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	1.2%	344,000	$6,140,000	—	31 Mar 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	1.2%	343,101	$6,124,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	1.2%	341,200	$6,090,000	—	31 Mar 2020	13F
Legal & General Group Plc	13F	Company	1.1%	330,409	$5,933,000	—	31 Mar 2020	13F
PDT Partners, LLC	13F	Company	1.1%	322,778	$5,762,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.1%	306,045	$5,463,000	—	31 Mar 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	1%	292,600	$5,223,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.97%	280,358	$5,004,000	—	31 Mar 2020	13F
Employees Retirement System of Texas	13F	Company	0.95%	273,015	$4,873,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.93%	267,623	$4,777,000	—	31 Mar 2020	13F
MACQUARIE GROUP LTD	13F	Company	0.92%	263,985	$4,712,000	—	31 Mar 2020	13F
Tekla Capital Management LLC	13F	Company	0.91%	263,079	$4,696,000	—	31 Mar 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.87%	252,004	$4,498,000	—	31 Mar 2020	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.87%	250,273	$4,467,373	—	31 Mar 2020	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.86%	247,761	$4,423,000	—	31 Mar 2020	13F

Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) as of Q2 2020

As of 30 Jun 2020, NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) was held by 249 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 174,896,826 shares. The largest 10 holders included Invesco Ltd., PRIMECAP MANAGEMENT CO/CA/, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, MAVERICK CAPITAL LTD, STATE STREET CORP, Bellevue Group AG, and FIRST TRUST ADVISORS LP. This page lists 250 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

234

Q2 2020 holders

249

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.